[1] |
PIZZI M, NG L. Neurologic complications of solid organ transplantation[J]. Neurol Clin, 2017, 35(4): 809-823. DOI: 10.1016/j.ncl.2017.06.013.
|
[2] |
LIPOWSKI D, POPIEL M, PERLEJEWSKI K, et al. A cluster of fatal tick-borne encephalitis virus infection in organ transplant setting[J]. J Infect Dis, 2017, 215(6): 896-901. DOI: 10.1093/infdis/jix040.
|
[3] |
POUCH SM, KATUGAHA SB, SHIEH WJ, et al. Transmission of eastern equine encephalitis virus from an organ donor to 3 transplant recipients[J]. Clin Infect Dis, 2019, 69(3): 450-458. DOI: 10.1093/cid/ciy923.
|
[4] |
SCHLOTTAU K, FORTH L, ANGSTWURM K, et al. Fatal encephalitic borna disease virus 1 in solid-organ transplant recipients[J]. N Engl J Med, 2018, 379(14): 1377-1379. DOI: 10.1056/NEJMc1803115.
|
[5] |
QI ZL, SUN LY, BAI J, et al. Japanese encephalitis following liver transplantation: a rare case report[J]. World J Clin Cases, 2020, 8(2): 337-342. DOI: 10.12998/wjcc.v8.i2.337.
|
[6] |
BONNAFOUS P, MARLET J, BOUVET D, et al. Fatal outcome after reactivation of inherited chromosomally integrated HHV-6A (iciHHV-6A) transmitted through liver transplantation[J]. Am J Transplant, 2018, 18(6): 1548-1551. DOI: 10.1111/ajt.14657.
|
[7] |
罗静, 程翼飞, 闫晨华, 等. 儿童单倍型造血干细胞移植后HHV-6病毒性脑炎二例报告并文献复习[J]. 中华血液学杂志, 2019, 40(2): 152-155. DOI: 10.3760/cma.j.issn.0253-2727.2019.02.012.LUO J, CHENG YF, YAN CH, et al. HHV-6 viral encephalitis after allogeneic hematopoietic stem cell transplantation in children: two cases report and literature review[J]. Chin J Hematol, 2019, 40(2): 152-155. DOI: 10.3760/cma.j.issn.0253-2727.2019.02.012.
|
[8] |
AGUT H, BONNAFOUS P, GAUTHERET-DEJEAN A. Laboratory and clinical aspects of human herpesvirus 6 infections[J]. Clin Microbiol Rev, 2015, 28(2): 313-335. DOI: 10.1128/CMR.00122-14.
|
[9] |
ELIASSEN E, HEMOND CC, SANTORO JD. HHV-6-associated neurological disease in children: epidemiologic, clinical, diagnostic, and treatment considerations[J]. Pediatr Neurol, 2020, 105: 10-20. DOI: 10.1016/j.pediatrneurol.2019.10.004.
|
[10] |
YLINEN E, LEHTINEN S, JAHNUKAINEN T, et al. Human herpes virus 6 infection in pediatric organ transplant patients[J]. Pediatr Transplant, 2017, 21(4). DOI: 10.1111/petr.12905.
|
[11] |
FERNÁNDEZ-RUIZ M, KUMAR D, HUSAIN S, et al. Utility of a monitoring strategy for human herpesviruses 6 and 7 viremia after liver transplantation: a randomized clinical trial[J]. Transplantation, 2015, 99(1): 106-113. DOI: 10.1097/TP.0000000000000306.
|
[12] |
PELLETT MADAN R, HAND J, AST Infectious Diseases Community of Practice. Human herpesvirus 6, 7, and 8 in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13518. DOI: 10.1111/ctr.13518.
|
[13] |
YASUI T, SUZUKI T, YOSHIKAWA T, et al. Clinical course of human herpesvirus 6 infection in pediatric living donor liver transplantation[J]. Pediatr Transplant, 2018, 22(7): e13239. DOI: 10.1111/petr.13239.
|
[14] |
INUI Y, YAKUSHIJIN K, OKAMURA A, et al. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation[J]. Transpl Infect Dis, 2019, 21(1): e13024. DOI: 10.1111/tid.13024.
|
[15] |
MIYASHITA N, ENDO T, ONOZAWA M, et al. Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation[J]. Transpl Infect Dis, 2017, 19(3): e12682. DOI: 10.1111/tid.12682.
|
[16] |
RAUBER C, BARTELHEIMER K, ZHOU T, et al. Prevalence of human herpesviruses in biliary fluid and their association with biliary complications after liver transplantation[J]. BMC Gastroenterol, 2019, 19(1): 110. DOI: 10.1186/s12876-019-1033-x.
|
[17] |
FIDA M, HAMDI AM, BRYSON A, et al. Long-term outcomes of patients with human herpesvirus 6 encephalitis[J]. Open Forum Infect Dis, 2019, 6(7): ofz269. DOI: 10.1093/ofid/ofz269.
|
[18] |
VICTORIA NC, PHAN TL, AGARWAL KA. A systematic review of sodium disorders in HHV-6 encephalitis[J]. Biol Blood Marrow Transplant, 2020, 26(5): 1034-1039. DOI: 10.1016/j.bbmt.2020.01.023.
|
[19] |
WARD KN, HILL JA, HUBACEK P, et al. Guidelines from the 2017 European conference on infections in leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation[J]. Haematologica, 2019, 104(11): 2155-2163. DOI: 10.3324/haematol.2019.223073.
|
[20] |
ABU SITTA E, KHAZAN A, LUTTMANN K, et al. HHV-6: an unusual cause of cerebellar ataxia[J]. BMJ Case Rep, 2020, 13(3): e234303. DOI: 10.1136/bcr-2020-234303.
|
[21] |
CAMUS V, BOUWYN JP, CHAMSEDDINE A, et al. Human herpesvirus-6 acute limbic encephalitis after unrelated umbilical cord blood transplantation successfully treated with ganciclovir[J]. Bone Marrow Transplant, 2015, 50(10): 1385-1387. DOI: 10.1038/bmt.2015.159.
|
[22] |
AGNIHOTRI SP. Central nervous system opportunistic infections[J]. Semin Neurol, 2019, 39(3): 383-390. DOI: 10.1055/s-0039-1687842.
|
[23] |
OGATA M, UCHIDA N, FUKUDA T, et al. Clinical practice recommendations for the diagnosis and management of human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation: the Japan Society for Hematopoietic Cell Transplantation[J]. Bone Marrow Transplant, 2020, 55(6): 1004-1013. DOI: 10.1038/s41409-019-0752-5.
|
[24] |
OGATA M, PHAN TL, FUKUDA T. Antiviral therapy for the treatment of HHV-6-associated syndromes after transplant[J]. Am J Transplant, 2019, 19(1): 306-307. DOI: 10.1111/ajt.15069.
|
[25] |
ONGRÁDI J, ABLASHI DV, YOSHIKAWA T, et al. Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals[J]. J Neurovirol, 2017, 23(1): 1-19. DOI: 10.1007/s13365-016-0473-0.
|
[26] |
CHEMALY RF, HILL JA, VOIGT S, et al. In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: a systematic literature review[J]. Antiviral Res, 2019, 163: 50-58. DOI: 10.1016/j.antiviral.2019.01.008.
|
[27] |
TOOMEY D, PHAN TL, NGUYEN V, et al. Retrospective case analysis of antiviral therapies for HHV-6 encephalitis after hematopoietic stem cell transplantation[J]. Transpl Infect Dis, 2021, 23(1): e13443. DOI: 10.1111/tid.13443.
|
[28] |
RIGHI E, CARNELUTTI A, MUSER D, et al. Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review[J]. J Neurovirol, 2017, 23(6): 908-912. DOI: 10.1007/s13365-017-0566-4.
|
[29] |
HOERSTER K, UHRBERG M, WIEK C, et al. HLA class I knockout converts allogeneic primary NK cells into suitable effectors for "Off-the-Shelf" immunotherapy[J]. Front Immunol, 2021, 11: 586168. DOI: 10.3389/fimmu.2020.586168.
|
[30] |
TZANNOU I, PAPADOPOULOU A, NAIK S, et al. Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation[J]. J Clin Oncol, 2017, 35(31): 3547-3557. DOI: 10.1200/JCO.2017.73.0655.
|
[31] |
HILL JA, NICHOLS WG, MARTY FM, et al. Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT[J]. Blood, 2020, 135(17): 1447-1451. DOI: 10.1182/blood.2019004315.
|
[32] |
OGATA M, TAKANO K, MORIUCHI Y, et al. Effects of prophylactic foscarnet on human herpesvirus-6 reactivation and encephalitis in cord blood transplant recipients: a prospective multicenter trial with an historical control group[J]. Biol Blood Marrow Transplant, 2018, 24(6): 1264-1273. DOI: 10.1016/j.bbmt.2018.02.008.
|